A new artificial intelligence tool, Hetairos, is significantly accelerating the diagnosis of brain tumors. Unlike traditional methods that can take weeks, Hetairos can identify over 100 molecular subtypes of central nervous system tumors from standard histological slides in a matter of minutes. This rapid identification is achieved through analysis of tissue samples, allowing for quicker and more precise diagnoses. The system promises to expedite the start of appropriate treatment plans for patients. Researchers believe Hetairos represents a substantial advancement in neuro-oncology, potentially improving patient outcomes. The technology focuses on analyzing molecular subtypes, offering a more detailed understanding of each tumor’s characteristics. This advancement could lead to more personalized and effective cancer therapies.